Immunohistochemical features of paragangliomas

Area of Science:

• Oncology
• Pathology
• Biochemistry

Background:

• Immunohistochemistry is crucial for diagnosing neuroendocrine tumors.
• Paragangliomas are rare neuroendocrine tumors requiring specific diagnostic markers.
• Existing diagnostic panels may lack specificity for certain paraganglioma subtypes.

Purpose of the Study:

• To evaluate a comprehensive immunohistochemistry panel for enhanced paraganglioma diagnosis.
• To investigate the expression of Bcl-2, Ki-67, Bax, PACAP, somatostatin, VIP, and CGRP in paragangliomas.
• To determine the potential prognostic value of these markers in paraganglioma behavior.

Main Methods:

• Analysis of 52 paragangliomas using routine histology and immunohistochemistry.
• Application of a complex panel including Bcl-2, Ki-67, Bax, Pituitary Adenylate Cyclase-Activating Peptide (PACAP), somatostatin, VIP, and Calcitonin Gene Related Peptide (CGRP).
• Immunostaining performed using StreptABC with DAB chromogen after heat-induced antigen retrieval.

Main Results:

• Demonstrated the presence of Bax and PACAP in paragangliomas for the first time.
• Observed a low percentage of Ki-67 positive cases, indicating low mitotic activity.
• Reported high Bax positivity (32.9%) and low Bcl-2 positivity (11.39%).

Conclusions:

• The expression patterns of Bax and Bcl-2 may influence apoptotic signaling and contribute to the benign behavior of paragangliomas.
• The studied markers, particularly Ki-67, Bax, and Bcl-2, show potential prognostic value.
• This complex immunohistochemistry panel aids in increasing diagnostic specificity for paragangliomas.